I

Iovance Biotherapeutics

TIL-based T-cell therapies for solid tumors

Cell Therapy Account Management

Account ManagementConfirmed live in the last 24 hours
Full-timeDenver, CO, USA$200k - $220k /yr

About the Job

Requirements

  • Eight to twelve years of related experience with a bachelor's degree, or six years of experience with a master's degree, or a PhD with three years of experience, or equivalent experience in a similar role within oncology, cell therapy, or rare disease.
  • Uses strategic foresight to optimize strategy and build service lines at academic hospitals.
  • Demonstrates deep market knowledge of the oncology and immunotherapy market, including reimbursement and policy landscapes within academic hospitals, oncology clinics, and extensive community practices.
  • Has prior experience with products and therapies requiring complex delivery systems, including logistics management and regulatory and compliance requirements such as Good Manufacturing Practices and quality systems.
  • Can coach and drive alignment with field-based and internal cross-functional partners.
  • Uses data analytics to optimize decision-making and planning around Amtagvi uptake strategy.
  • Must have a valid driver's license.

Responsibilities

  • Drive Amtagvi demand and appropriate pull-through at targeted authorized treatment centers and serve as a liaison between community oncology practices and internal stakeholders to align initiatives with business and medical objectives.
  • Serve as the primary commercial point of contact for the Iovance iPOD at authorized treatment centers offering commercially available Amtagvi, and lead development and onboarding of a new tumor-infiltrating lymphocyte service line at target centers.
  • Educate site personnel on clinical and product information for Amtagvi.
  • Provide knowledge and expertise about Iovance products and processes to service-line customer stakeholders.
  • Collaborate with authorized treatment center operations, aligning Iovance cell therapy logistics, processes, and operations.
  • Build business relationships with key clinical thought leaders, Amtagvi prescribers, and other institutional stakeholders to influence uptake while providing customer service.
  • Develop and maintain knowledge of disease states, Amtagvi, and the competitive landscape.
  • Attend and support professional meetings and congresses regionally and nationally.
  • Facilitate engagement with key thought leaders, cell therapy prescribers, and other institutional stakeholders.
  • Collaborate with Market Access, Operations, Quality, Marketing, Medical, and other cross-functional partners to support appropriate patient identification, Amtagvi infusion, and clinical care.
  • Provide timely feedback to Iovance management on account business trends, therapeutic landscape changes, industry issues, and business opportunities.
  • Collaborate with sales leadership to develop and implement strategic account plans in qualified academic institutions and large community medical oncology practices.
  • Maintain compliance with U.S. and global healthcare laws and regulations.
  • Follow Iovance Biotherapeutics' core values, policies, procedures, and business ethics.
  • Perform other assigned duties.

Desired Qualifications

  • Oncology, cell therapy, or rare disease experience.
  • An MBA or other related graduate-level degree.
  • New product launch experience.
  • Experience in oncology care, new product launches, and cell therapy.

About the Company

Iovance Biotherapeutics

TIL-based T-cell therapies for solid tumors

Iovance Biotherapeutics develops cancer immunotherapies using Tumor Infiltrating Lymphocytes (TIL). It harvests T cells from a patient’s tumor, expands them in the lab, and infuses them back into the patient to attack solid tumors. The therapies are designed as single-treatment treatments without the need for ongoing maintenance. The company differentiates itself by focusing on TIL-based adoptive cell therapy with broad antigen targeting and dedicated cell therapy manufacturing capabilities, including the Iovance Cell Therapy Center (iCTC) to scale production. Its goal is to develop, manufacture, and commercialize proprietary TIL therapies and expand access to cell-based cancer treatments through partnerships and scaled production.

Company size
501-1,000
Company stage
IPO
Headquarters
San Carlos, CA
Founded
2007

Recently Posted Jobs

Explore more opportunities at Iovance Biotherapeutics

See more jobs